Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipolat vs Latanoprost in Glaucoma/OHT
NCT02466399Phase 2Completed
- Sponsor
- Peregrine Ophthalmic
- Start
- Jul 2015
- Primary completion
- Apr 2016
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liposomal latanoprost in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by Peregrine Ophthalmic. Started Jul 2015; status: completed.
02
Drugs
liposomal latanoprost
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT02466399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02466399.